Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-08-01 to 2023-08-02
Current total value of award: $57.76
Description: 4561739999!DEPO-MEDROL 40 MG/ML VIALML